The effect of UDCA therapy on the development of esophageal varices was addressed in a prospective study of 180 PBC patients who received UDCA versus placebo and were observed for up to 4 years ...

SAN FRANCISCO, April 24, 2025--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about change on Earth, today announced a multi-year contract with EMDYN, a European-based ...

Primary biliary cholangitis (PBC) is an autoimmune disorder that leads to the destruction of bile ducts within the liver. As more bile ducts become lost and damaged, bile acids build up within the ...